A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH

A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 100 participants.

Also called NCT02284737

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02284737
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02284737. Randomized; single masking; primary purpose treatment. Start 2014-11-28 (actual); primary completion 2021-07-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
Acronym
PADN-PAH
Condition
Pulmonary Arterial Hypertension
Intervention (Procedure)
PADN
Intervention (Procedure)
sham PADN
Intervention (Drug)
Sildenafil
Lead sponsor
Nanjing First Hospital, Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct02284737
Content hash
c2df338e8f5fa16a3de6bfb77952c1ab220ff4708e50d0ce24ab4d0e0ee9e4f1